Disruptive technology: new medical advances are troublesome for even the most successful health systems and innovator health companies.
An independent expert panel conducted a multi-year research/education/advocacy initiative on the impact of the new drug-eluting stent technology. They conclude that this technology represents a "tipping point" in a series of transformative drugs and medical devices, often used in combination, and recommend that healthcare decision makers develop careful, data-based strategies to avoid the disruptiveness of these medical advances.
Michaelis
Lawrence
L
Northwestern Memorial Hospital, Chicago, IL, USA.
Vaul
Joanne
J
Chumer
Kathleen
K
Faul
Maureen
M
Sheehan
Lisa
L
DeCerce
Jack
J
D003659:Decision Making, Organizational; D003695:Delivery of Health Care / Q000458:organization & administration; D004059:Diffusion of Innovation; D016503:Drug Delivery Systems; D004864:Equipment and Supplies / Q000009:adverse effects*; D015607:Stents; D014481:United States